insights_auto
Por qué ha bajado BVNRY 2,79%?
Profundizarchevron_right
BVNRY:OTCMKTS
Bavarian Nordic A/S - ADR
10,80 US$
arrow_downward
-2,79%(-0,31) 1 d
1 oct, 14:20:33 GMT-4 · USD
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de BVNRY...
Abrir
10,81 US$
Alto
10,81 US$
Bajo
10,80 US$
Cap. burs.
2584,00 M
Vol. medio
2,76 mil
Volumen
11,35 mil
Ratio PER
11,47
Máximo en 52 sem.
13,00 US$
Mínimo en 52 sem.
8,67 US$
BPA
0,94 US$
Beta
1,40
Acciones en circulación
237,82 M
N.º de empleados
2 mil
Abrir
10,81 US$
Alto
10,81 US$
Bajo
10,80 US$
Cap. burs.
2584,00 M
Vol. medio
2,76 mil
Volumen
11,35 mil
Ratio PER
11,47
Máximo en 52 sem.
13,00 US$
Mínimo en 52 sem.
8,67 US$
BPA
0,94 US$
Beta
1,40
Acciones en circulación
237,82 M
N.º de empleados
2 mil
Noticias
De fuentes web y partners de noticias
MarketScreener España
·
hace 24 minutos
Las bolsas se dan la vuelta al alza tras moderarse los rendimientos del Tesoro desde máximos
Negocios.com
·
hace 57 minutos
Wall Street y Dow Jones: Los mercados miran de reojo a 1929 y 2008
Perfil
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
Acerca de Bavarian Nordic A/S - ADR